Can epoetin alfa maintain ribavirin doses in patients with hepatitis C virus on combination therapy?
Nature Clinical Practice Gastroenterology & Hepatology · 2004
DOI: 10.1038/ncpgasthep0016 ↗Kurz gefasst
Kommentar in der Zeitschrift Nature Clinical Practice Gastroenterology & Hepatology, 2004. Verfasst von Heiner Wedemeyer und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
Zitieren
APA
Wedemeyer, H., & Manns, M. P. (2004). Can epoetin alfa maintain ribavirin doses in patients with hepatitis C virus on combination therapy?. Nature Clinical Practice Gastroenterology & Hepatology. https://doi.org/10.1038/ncpgasthep0016
Vancouver
Wedemeyer H, Manns MP. Can epoetin alfa maintain ribavirin doses in patients with hepatitis C virus on combination therapy?. Nature Clinical Practice Gastroenterology & Hepatology. 2004. doi:10.1038/ncpgasthep0016
BibTeX
@article{Wedemeyer2004,
author = {Wedemeyer, Heiner and Manns, Michael P},
title = {Can epoetin alfa maintain ribavirin doses in patients with hepatitis C virus on combination therapy?},
journal = {Nature Clinical Practice Gastroenterology & Hepatology},
year = {2004},
doi = {10.1038/ncpgasthep0016}
}
EUVIMED